Life SciencesLiability

Products tower sizing

$5M vs $10M products liability tower. When the extra layer is worth it.

The products and completed operations tower is the single most important coverage line for most life-sciences operators. The sizing decision — typically between $5M and $10M, occasionally up to $25M or beyond — drives a meaningful share of total program premium and determines whether the operator is compliant with sponsor MSAs at the high end of the market.

This page covers the practical tradeoff: what each tower size satisfies, what it costs incrementally, and the breakpoints where stepping up from $5M to $10M moves from optional to mandatory.

Last updated 2026-05-12

Side-by-side

Where each tower size fits.

Dimension
$5M Products Tower
$10M Products Tower
Sponsor MSA fit
Satisfies most generic-pharma sponsor MSAs, lower-risk innovator sponsors, and many medical-device GPO supplier requirements.
Required by most branded innovator sponsor MSAs, by hospital purchase contracts at 503B scale, and by Class III medical-device GPO contracts.
Product class fit
Oral solid dose, topicals, OTC, lower-risk medical devices, basic compounding.
Sterile injectables, biologics, oncology drugs, Class III medical devices, implantables, GLP-1 compounding, recall-prone categories.
Typical tower structure
$1M primary CGL/products + $4M umbrella; sometimes $2M primary + $3M excess.
$1M primary + $4M umbrella + $5M excess; or $5M primary + $5M excess; or single $10M monoline.
Annual premium (Texas, $20M revenue, oral solid dose)
$22,000-$50,000
$40,000-$95,000
Annual premium (Texas, $20M revenue, sterile injectables)
$45,000-$95,000 (and may be inadequate for sponsor requirements)
$80,000-$200,000
Marginal premium for the extra $5M
Typically $18,000-$80,000 incremental — meaningful but smaller than the cost of non-compliance on a high-value engagement.
Aggregate exhaustion risk
Higher — a single $3M-$4M claim erodes the program substantially; subsequent sponsors share the eroded aggregate.
Lower — meaningful headroom even after a serious claim. Per-project or per-location aggregate endorsements still recommended where multiple sponsors share the tower.
When to size up to $10M
Whenever (a) sponsor MSA requires it, (b) product class warrants severity protection, (c) operator serves multiple sponsors and aggregate erosion risk is real, (d) hospital purchase contract requires it for 503B operators.
When $5M is sufficient
Sponsor MSAs are clearly $5M only, product class is lower-severity, operator serves a small number of sponsors with predictable claim profiles.

Frequently asked

Common questions from CDMO and CRO buyers

When do sponsor MSAs require $10M products liability instead of $5M?

+

Branded innovator sponsor MSAs, hospital purchase contracts at 503B scale, and most Class III medical-device GPO contracts typically require $10M products at minimum. Some innovator MSAs for biologics, oncology, or injectable products require $25M+. Generic-pharma sponsor MSAs typically accept $5M.

How much more does a $10M products tower cost than $5M?

+

For a Texas CDMO at $20M revenue manufacturing oral solid dose, the premium delta is typically $15,000-$35,000 annually. For sterile injectables at the same revenue, the delta runs $30,000-$80,000+ depending on product class. The marginal cost is meaningful but smaller than the cost of being out of compliance on a single high-value engagement.

What is "aggregate exhaustion" and why does it matter at $5M?

+

A products policy with $5M aggregate means total claims paid in one policy period are capped at $5M. A single $3M-$4M claim materially erodes the aggregate, leaving the operator under-insured for the remainder of the policy period. Operators serving multiple sponsors with shared aggregate face compounding exposure; per-project or per-location aggregate endorsements help.

Should small CDMOs carry $10M products even when sponsor MSAs only require $5M?

+

Often yes — for two reasons. First, sponsor MSAs change at renewal; if a sponsor moves from $5M to $10M, the operator needs the tower ready. Second, aggregate exhaustion risk scales with sponsor count; multi-sponsor operators benefit from headroom even when no single MSA requires it.

Is $10M products liability available from a single carrier?

+

Sometimes — specialty life-sciences markets writing monoline $10M occur. More commonly the tower is built in layers: $1M primary CGL/products + $4M umbrella + $5M excess from a second carrier. The layered structure is typically more economical than monoline at $10M.

Free coverage review

A specialist will reach out by the end of the day.

Request the review

A specialist will reach out by the end of the day.

We will use this only to schedule the review. No marketing sequences, no list rental.